Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FEEDBACK PLC Director's Dealing 2018

Nov 19, 2018

7636_dirs_2018-11-19_e391a20a-08dc-429f-9f89-cbac1cae44e2.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8058H

Feedback PLC

19 November 2018

19 November 2018

Feedback plc

Director/PDMR Shareholdings

Cambridge, 19 November 2018: Further to the announcement on 15 November 2018, Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces the following changes to the interests of the Directors of the Company following the admission to trading on AIM of the New Ordinary Shares issued pursuant to the Subscription.  

Director/PDMR Subscription Shares subscribed for Total number of Ordinary Shares now held % of Company's issued share capital
Dr Alastair Riddell 1,000,000 7,000,000 1.88
Lindsay Melvin 600,000 600,000 0.16
Simon Sturge 5,333,333 12,833,333 3.44

Capitalised terms used but not defined in this announcement shall have the meanings given to such terms in the circular issued by the Company dated 25 October 2018 unless otherwise defined herein.

Enquiries:
Feedback plc

Alastair Riddell, Executive Chairman

Lindsay Melvin, CFO
+44 (0)1954 718072

[email protected]
Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai
+44 (0)20 3328 5656
Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey
+44 (0)20 7469 0936
Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

Instinctif Partners

Rozi Morris/ Deborah Bell/ Phillip Marriage
+44 20 3815 8880

+44 (0)20 7457 2020

[email protected]

Notes to editors

About Feedback plc 

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS). For more information, see www.fbk.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHGGGAAGUPRGCB